HIV Learning Network: HIV and Primary Care Update: Diabetes Medications

Join us for the next HIV Learning Network session on April 27 @ 12:00pm (Pacific) for HIV and Primary Care Update: Diabetes Medications, by Kirsten Balano, PharmD, AAHIVP, HIVLN Faculty, Pacific AETC Pharmacy Lead, Associate Professor of Clinical Pharmacy, UCSF.

Description: The number of people living with HIV and AIDS (PWHA) reached to almost 40 million, half of which are under antiretroviral treatment (ART). Although the introduction of this therapy significantly improved the life span and quality of PWHA, metabolic complications of these people remains to be an important issue. These metabolic complications include hyperlipidemia, abnormal fat redistribution and diabetes mellitus, which are defined as lipodystrophy syndrome. (Culha MG, et al. Med Hypotheses. 2016) Glucagon-like peptide-1 agonists are a class of medications utilized in the treatment of type 2 diabetes and obesity. In this session, Dr. Kirsten Balano, PharmD, AAAHIVP, will review these class of drugs and discuss their benefits and precautions for treating HIV-associated metabolic adverse effects, and therefore improve the quality and length of life in people with HIV.

Learning Objectives:
Upon completion of this session, participants will be able to:

1. Describe the value of Glucogon-like-protein-1 Receptor Agonists (GLP-1RA) for weight loss.
2. Apply updated diabetes standards to patients with HIV and Diabetes Type 2.
3. Investigate resources to access to GLP1RA for patients with HIV.

Physicians:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada School of Medicine and the Pacific AIDS Education and Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:
Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement.

HIV Learning Network offers free CME for participants attending sessions, pending completion of the post-session evaluation.